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BACKGROUND: Lead is toxic and affects neurodevelopment in children even at low levels. There has been a
long-term effort in the United States to reduce exposure to lead in the environment. We studied the latest
US population blood lead levels and analyzed its trend.
METHOD: Blood lead levels in 63,890 participants of the National Health Nutrition and Examination Survey
1999-2014 were analyzed using SPSS Complex Samples v22.0 (IBM Corp, Armonk, NY).
RESULTS:Mean blood lead levels and 95% conﬁdence intervals (CIs) were 1.65 mg/dL (1.62-1.68), 1.44 mg/
dL (1.42-1.47), 1.43 mg/dL (1.40-1.45), 1.29 mg/dL (1.27-1.32), 1.27 mg/dL (1.25-1.29), 1.12 mg/dL (1.10-
1.14), 0.97 mg/dL (0.95-0.99), and 0.84 mg/dL (0.82-0.86) in 1999-2000, 2001-2002, 2003-2004, 2005-
2006, 2007-2008, 2009-2010, 2011-2012, and 2013-2014, respectively. Blood lead levels decreased
signiﬁcantly (P <.001), and the trend remained signiﬁcant when stratiﬁed by age, gender, ethnicity, and
pregnancy status (P <.05). Estimated percentages of children with blood lead level 5 mg/dL were 9.9%
(95% CI, 7.5-12.9), 7.4% (95% CI, 5.9-9.4), 5.3% (95% CI, 4.1-6.9), 2.9% (95% CI, 2.1-3.9), 3.1% (95%
CI, 2.0-4.8), 2.1% (95% CI, 1.5-3.1), 2.0% (95% CI, 1.0-3.6), and 0.5% (95% CI, 0.3-1.0) in 1999-2000,
2001-2002, 2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012, and 2013-2014, respectively. The
decreasing trend was signiﬁcant (P <.05). In children aged 1 to 5 years in the National Health Nutrition and
Examination Survey 2011-2014, the estimated 97.5 percentile of blood lead level was 3.48 mg/dL.
CONCLUSIONS: Blood lead levels have been decreasing in the US population. The reference level also
should decrease. It is still important to monitor blood lead levels in the population, especially among
pregnant women and children aged 1 to 5 years.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).  The American Journal of Medicine (2016)
129, 1213-1218
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.1016/j.amjmed.2016.05.042Lead is ubiquitous in the environment but has no known
biological role in humans.1 It can form complexes with
amino acids, proteins, and thiol-containing compounds,
resulting in inhibition of enzymes and induction of
oxidative stress.2 In adults, lead is well known for causing
toxicity to the bone marrow, liver, kidney, and central
nervous system. Recent studies also showed that high
blood lead levels are associated with an increase in systolic
blood pressure and mortality.3-5 Pregnant women withrticle under the CC BY-NC-ND license (http://creativecommons.org/licenses/
1214 The American Journal of Medicine, Vol 129, No 11, November 2016high blood lead levels are at risk of spontaneous abor-
tion.6,7 However, children are at the highest risk of lead
poisoning. High blood lead levels are associated with
reduced intelligence, attention deﬁcit hyperactivity disor-
der, hearing impairment, and delayed puberty in girls.7-9
Chelation therapy can be considered in children with aCLINICAL SIGNIFICANCE
 There has been a continuous decreasing
trend in blood lead levels in the US
population.
 The reference level should be revised to
reﬂect the decrease in blood lead levels
in the United States.
 The upper reference level for blood lead
should be reduced to 3.5 mg/dL.blood lead level of 45 mg/dL or
greater,10 but there is no evidence
to show that chelation therapy is
associated with any improvement
in intelligence.11 Because lead
exposure can result in irreversible
harm in children,11,12 reducing
blood lead levels in the popula-
tion is desirable. This is best
achieved by reducing lead in the
environment.
The current upper reference
level for blood lead is 5 mg/dL in
the United States. This reference
level was set in 2012 using the
97.5th percentile of blood lead levels in children aged 1 to 5
years in the National Health Nutrition and Examination
Survey (NHANES) 2007-2010.13 Previous studies have
shown a decrease in blood lead levels in the US population
over the years.14-16
However, as the events in Flint, Michigan, have
shown, there is no room for complacency. The crisis was
due to a decision made by the local government to use
Flint River as the source for tap water. The proportion
of children aged 1 to 5 years with a blood lead level 5
mg/dL was 2.5%.17 Therefore, we analyzed the trend in
blood lead levels in the US population using the latest
data from NHANES and estimated the proportion of
children with an elevated lead level, deﬁned as 5 mg/dL or
greater.MATERIALS AND METHODS
NHANES is a continuous national survey conducted by
the US Centers for Disease Control and Prevention.
Detailed methodology and protocols are described on its
webpage.18 Each participant represents approximately
50,000 Americans. The study was approved by the Research
Ethics Review Board at the National Center for Health
Statistics. All participants gave informed consent.
We used the NHANES dataset from 1999 to 2014. For
inclusion in the analysis, a blood lead level had to be
available. Included participants were stratiﬁed according to
the year of survey, age, gender, ethnicity, poverty income
ratio, and pregnancy status.
Venous blood samples were obtained to measure blood
lead levels according to a standard protocol. Samples were
frozen at 20C and shipped in dry ice until analysis. After
thawing, samples were diluted and analyzed with an
Inductively Coupled Plasma Dynamic Reaction Cell Mass
Spectrometer (ELAN DRC II, PerkinElmer, Norwalk).19The limits of detection were 0.3 mg/dL in 1999-2002, 0.28
mg/dL in 2003-2004, 0.25 mg/dL in 2003-2012, and 0.07 mg/
dL in 2013-2014. Blood lead levels below the lower limit of
detection were assigned a value equal to the lower detection
limit divided by O2.Statistical Analysis
Results were analyzed using SPSS
complex sample module version
22.0 (IBM Corp, Armonk, NY).
Sample weights were applied to
account for unequal probabilities
of selection, nonresponse bias, and
oversampling. Natural logarithm-
transformed blood lead levels
were used to normalize the distri-
bution of blood lead levels.
The proportions of children
aged 1 to 5 years and pregnant
women with elevated blood leadlevel, deﬁned as 5 mg/dL or greater, were estimated. Blood
lead levels were expressed as geometric means and 95%
conﬁdence intervals (CIs). Categoric variables were
expressed as percentages. Analysis of variance or t test was
used to compare blood lead levels in different groups in the
same sampling period. Multiple regression was used to
analyze trends in blood lead level across sampling periods.
A 2-tailed P value of <.05 was considered statistically
signiﬁcant. The 97.5th percentile of the blood lead level in
children aged 1 to 5 years in NHANES 2011-2014 also was
estimated.RESULTS
We analyzed 7970, 8946, 8373, 8407, 8266, 8793, 7920,
and 5215 participants in NHANES 1999-2000, 2001-2002,
2003-2004, 2005-2006, 2007-2008, 2009-2010, 2011-2012,
and 2013-2014, respectively. The characteristics of these
participants are summarized in Table 1. Mean blood lead
levels decreased from 1.65 mg/dL (95% CI, 1.62-1.68) in
1999-2000 to 0.84 mg/dL (95% CI, 0.82-0.86) in 2013-
2014 (Table 1). The decreasing trend of blood lead levels
across the years was signiﬁcant (P <.001).
We further analyzed subgroups stratiﬁed by age, gender,
and ethnicity. Mean blood lead levels stratiﬁed by age are
summarized in Figure 1. There was a signiﬁcant reduction
in blood lead levels in all age groups (P <.001)
(Figure 1). Blood lead levels stratiﬁed by age and gender
are summarized in Supplementary Table 1, available on-
line. There was a signiﬁcant decrease (P <.001) in all age
groups and genders. Blood lead levels stratiﬁed by ethnicity
are summarized in Supplementary Table 2, available online.
Other ethnicities have been further divided into non-
Hispanic Asians and other race since NHANES 2011-
2012 (Supplementary Table 2, available online). The
decrease in blood lead levels was signiﬁcant in all ethnicities
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Tsoi et al Decrease in the US Blood Lead Level 1999-2014 1215(P <.05) except other race (P ¼ .454) (Supplementary
Table 2, available online).
The mean blood lead levels in pregnant women and in
children aged 1 to 5 years are summarized in Supplementary
Table 3, available online. The proportion of pregnant women
with elevated blood lead level also decreased with marginal
signiﬁcance (P ¼ .053) (Table 2). The proportion of children
aged 1 to 5 years with an elevated lead level decreased from
9.9% (95% CI, 7.5-12.9) in 1999-2000 to 0.5% (95% CI,
0.3-1.0) in 2013-2014 (P <.001) (Figure 2). The estimated
97.5th percentile of the blood lead level in children aged 1
to 5 years in NHANES 2011-2014 was 3.48 mg/dL.DISCUSSION
Data from NHANES were used because it is a large-scale
survey representative of the US noninstitutionalized popu-
lation.20 Moreover, participants of all ages, including in-
fants, children, and pregnant women, were included. The
protocol in NHANES is standardized and therefore facili-
tates comparison across the years. Lead was measured in a
centralized laboratory according to a strict protocol.
Previous studies have reported a decreasing trend in
blood lead levels in the US populations among different age
groups and ethnicities.13,16,21,22 Our analysis conﬁrmed this
decreasing trend and showed that there were further de-
creases in recent years. This is encouraging and demon-
strates the effectiveness of long-term measures to reduce
lead exposure in the United States. Compared with the re-
sults of the Canadian Health and Measures Survey and the
Korean National Health and Nutrition Examination Survey
in the corresponding age groups, the mean blood lead levels
in NHANES were lower.23,24
We found that less than 1% of children had a blood lead
level 5 mg/dL in 2013-2014. There were no pregnant
women in the sample population with an elevated blood lead
level. It may be timely to revise the blood lead reference
level to reﬂect the decrease in blood lead levels in the United
States. Our analysis suggested that the upper reference level
for blood lead should be reduced to 3.5 mg/dL.
In contrast to the declining blood lead levels across the
United States, the switch to Flint River as the source of
water resulted in increased release of lead in pipes and
elevated blood lead level in the residents of Flint, Michi-
gan.25,26 In children, this is of particular concern because
lead is detrimental to neurocognitive development. The
lesson that should be learned is that public health measures
to monitor and reduce population exposure to lead in the
environment should not be relaxed. Continued vigilance is
essential to good public health.Study Limitations
Our analysis was not without limitations. The study popu-
lation was not a cohort, and the participants, who were
chosen randomly, differed in successive surveys. Blood
samples were obtained only once in each participant, so
Table 2 Estimated Proportion of Pregnant Women and Children Aged 1 to 5 Years of Different Ethnicities and Poverty Income Ratios with Elevated Blood Lead Level in 1999-2014
Year 1999-2000 2001-2002 2003-2004 2005-2006 2007-2008 2009-2010 2011-2012 2013-2014 P
Pregnant women 0.7% (0.2-2.6) 0.2% (0.0-1.1) 0.9% (0.1-6.3) 0.0% 0.0% 0.0% 0.0% 0.0% .053
Children aged 1-5 y
Stratiﬁed by genders
Male 7.9% (6.8-9.2) 5.9% (5.1-6.8) 4.5% (3.8-5.3) 3.4% (2.8-4.1) 3.9% (3.2-4.8) 2.9% (2.3-3.6) 2.5% (1.9-3.3) 2.4% (1.7-3.5) .001
Female 2.8% (2.1-3.6) 1.9% (1.5-2.5) 1.6% (1.3-2.0) 1.3% (1.0-1.8) 1.1% (0.8-1.5) 0.8% (0.5-1.1) 1.2% (0.8-1.9) 0.3% (0.2-0.6) .001
Stratiﬁed by ethnicities
Mexican Americans 10.2% (7.2-14.2) 4.3% (2.5-7.4) 3.7% (2.0-6.7) 1.4% (0.5-3.9) 1.2% (0.5-3.3) 2.6% (1.3-5.1) 0.0% 0.5% (0.1-3.2) .001
Other Hispanics 3.6% (1.2-10.4) 6.6% (3.1-13.5) 3.3% (0.4-20.4) 6.9% (2.9-15.4) 1.1% (0.1-7.2) 1.7% (0.4-6.8) 1.0% (0.1-7.2) 0.7% (0.1-4.7) .049
Non-Hispanic white 9.4% (5.9-14.7) 5.5% (3.5-8.7) 2.9% (1.5-5.5) 1.6% (0.8-3.2) 3.1% (1.5-6.0) 1.65% (0.8-3.10) 2.8% (1.2-6.6) 0.0% .001
Non-Hispanic black 19.1% (14.0-25.5) 18.0% (14.0-22.9) 16.4% (12.7-20.8) 7.8% (5.4-11.3) 7.1% (4.3-11.4) 3.8% (1.8-7.9) 3.2% (1.6-6.4) 1.6% (0.6-4.1) .001
Others 2.6% (0.4-5.9) 8.8% (3.1-22.7) 4.9% (1.9-12.0) 3.8% (1.4-10.4) 1.2% (0.2-8.6) 1.7% (0.4-6.9) 0.0% 1.3% (0.4-4.0) .027
Non-Hispanic Asian NA NA NA NA NA NA 0.0% 0.8% (0.1-5.4) .267
Other race, including multiracial NA NA NA NA NA NA 0.0% 1.1% (0.3-3.9) .001
Stratiﬁed by poverty income ratio
<1.3 14.0% (10.2-18.9) 12.7% (9.8-16.1) 8.9% (6.7-11.7) 6.7% (4.8-9.2) 4.8% (3.3-7.1) 4.1% (2.7-6.0) 3.1% (1.6-5.9) 1.1% (0.5-2.0) .001
1.3 6.2% (3.6-10.4) 2.7% (1.5-5.1) 2.5% (1.3-4.8) 0.9% (0.4-2.1) 1.9% (0.7-4.9) 0.6% (0.2-1.6) 0.8% (0.1-4.5) 0.0% .001
Stratiﬁed by age
1-2 y 11.8% (8.2-16.5) 12.1% (9.1-16.0) 7.7% (5.3-11.0) 3.6% (2.4-5.4) 3.4% (2.1-5.4) 2.9% (1.8-4.7) 3.3% (1.4-7.6) 0.9% (0.4-2.0) .001
3-5 y 8.4% (5.5-12.6) 4.5% (2.9-6.8) 3.6% (2.5-5.4) 2.5% (1.5-4.0) 3.0% (1.6-5.6) 1.6% (0.9-2.9) 1.3% (0.5-3.3) 0.3% (0.1-0.9) .001
NA ¼ not applicable.
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Figure 1 Estimated mean blood lead level in participants in different age groups in 1999-2014.
Tsoi et al Decrease in the US Blood Lead Level 1999-2014 1217ﬂuctuations of blood levels with time among individuals
could not be captured. Because lead is mainly deposited in
bones, the cumulative exposure of lead could not be
measured simply by blood test. This is especially relevant to
immigrants, who may have been exposed to lead before
living in the United States. Immigrants and refugees withinFigure 2 Estimated proportion of children aged 1 to6 months of arrival in the United States are more likely to
have elevated blood lead levels.27-29 The Centers for
Disease Control and Prevention has introduced a program
to monitor population groups. Previous studies showed
elevated blood lead levels in Mexican Americans25 and the
poor,20 but this was not evident in the latest NHANES data.5 years with elevated lead level in 1999-2014.
1218 The American Journal of Medicine, Vol 129, No 11, November 2016CONCLUSIONS
There has been a continuous decreasing trend in blood lead
levels in the US population. Because blood lead level in
young children is a very important health issue, monitoring
of blood lead levels at the population level should be
continued.
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